MedImmune v. Genentech: Impact of the Supreme Court Jan. 9 Decision on Patent Licenses
Court Overturns Long-Standing Federal Circuit Position
Recording of a 90-minute premium CLE webinar with Q&A
Benefits
The panel will review these and other key questions:
- How has Medimmune shifted the balance of power between patent owners and licensees – and how can licensors protect their rights?
- How will Medimmune impact license negotiations and enforcement?
- What are the best practices for licensors to protect themselves from patent challenges by licensees?
Faculty
Michael A. O'Shea
Partner
Akin Gump Strauss Hauer & Feld
He focuses his practice on patent litigation and licensing. He has litigated numerous patent cases in a wide range of... | Read More
He focuses his practice on patent litigation and licensing. He has litigated numerous patent cases in a wide range of technologies and in jurisdictions nationwide, including the International Trade Commission.
CloseCharles Baker
Partner
Porter & Hedges
He prosecutes and defends complex civil litigation matters, including significant high-profile work on IP matters. He... | Read More
He prosecutes and defends complex civil litigation matters, including significant high-profile work on IP matters. He has been selected as a Texas Super Lawyer in IP Litigation since 2005.
CloseDavid Segal
Partner
Gibson Dunn & Crutcher
He is a member of the firm's IP and Technology Practice Groups. He has substantial litigation and transactional... | Read More
He is a member of the firm's IP and Technology Practice Groups. He has substantial litigation and transactional experience in patent, trademark, and copyright matters.
Close